Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.6M Buy
153,622
+6,969
+5% +$2.39M 0.3% 56
2026
Q1
$51.6M Buy
146,653
+4,651
+3% +$1.66M 0.34% 53
2025
Q4
$46.5M Buy
142,002
+5,269
+4% +$1.67M 0.3% 57
2025
Q3
$38.6M Buy
136,733
+5,299
+4% +$1.54M 0.27% 70
2025
Q2
$36.7M Buy
131,434
+8,047
+7% +$2.28M 0.29% 66
2025
Q1
$38.4M Buy
123,387
+6,839
+6% +$2.02M 0.35% 50
2024
Q4
$30.4M Buy
116,548
+7,089
+6% +$2.1M 0.28% 66
2024
Q3
$35.3M Buy
109,459
+7,237
+7% +$2.37M 0.36% 53
2024
Q2
$31.9M Buy
102,222
+8,089
+9% +$2.38M 0.37% 47
2024
Q1
$26.8M Buy
94,133
+384
+0.4% +$112K 0.35% 55
2023
Q4
$27M Buy
93,749
+260
+0.3% +$70.8K 0.39% 48
2023
Q3
$25.1M Buy
93,489
+30,236
+48% +$7.55M 0.4% 46
2023
Q2
$14M Buy
63,253
+348
+0.6% +$80.7K 0.32% 66
2023
Q1
$15.2M Buy
62,905
+440
+0.7% +$108K 0.38% 55
2022
Q4
$16.4M Buy
62,465
+298
+0.5% +$79.9K 0.44% 49
2022
Q3
$14M Buy
+62,167
New +$15.1M 0.4% 51

Other funds holding AMGN

Czech National Bank's AMGN Position: Q2 2026 in Review

Czech National Bank increased its Amgen (AMGN) stake by 4.8% in Q2 2026, buying an estimated $2.39M and bringing the position to 153,622 shares worth $55.6M. The position accounts for 0.3% of the portfolio, ranked #56.

Czech National Bank first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. 1,183 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Czech National Bank held 153,622 shares of Amgen worth $55.6M as of Q2 2026.
  • Czech National Bank bought 6,969 Amgen shares in Q2 2026, an estimated $2.39M.
  • Amgen made up 0.3% of Czech National Bank's portfolio in Q2 2026, its #56 holding.
  • Czech National Bank first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • 1,183 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.